MDM2 and breast carcinoma: The MDM2 homolog MDMX (also called MDM4) promotes breast cancer and can inhibit the transcriptional activity of p53 and promote p53 degradation by heterodimerizing with MDM2 [8, 9], but its p53-independent functions are understudied.